Wholesale XCE Tirzepatide - High Potency Dual GIP and GLP-1 Receptor Agonist

XCE Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for metabolic research applications. This synthetic peptide demonstrates superior efficacy in glucose regulation and weight management compared to single-receptor agonists.

The XCE Tirzepatide compound features a unique molecular structure (C225H348N48O68) that provides enhanced binding affinity to both GIP and GLP-1 receptors. Research indicates this dual mechanism of action produces more significant improvements in glycemic control than selective GLP-1 receptor agonists alone.

Our pharmaceutical-grade XCE Tirzepatide is supplied as a white lyophilized powder with minimum 99% purity (HPLC verified). The product is carefully packaged to maintain stability and potency throughout storage and transportation.

For research purposes only. Not intended for human consumption or diagnostic use. Proper handling procedures should be followed by qualified researchers in controlled laboratory settings.

Current studies suggest XCE Tirzepatide may offer advantages in metabolic research areas including: glucose homeostasis, insulin sensitivity, appetite regulation, and body weight management. The compound's unique dual-receptor activity makes it particularly valuable for comparative pharmacological studies.

Researchers should note that XCE Tirzepatide requires proper reconstitution and handling to maintain stability. Optimal storage conditions include protection from light and moisture at controlled temperatures.